News

Abbott announced late-breaking data for its next-generation Navitor™ transcatheter aortic valve implantation (TAVI) system.

Researchers may be able to predict cardiovascular disease – such as atrial fibrillation and heart failure – in patients by using artificial intelligence (AI) to examine the genes in their DNA, according to a new Rutgers study.

An earlier first birth, a higher number of live births, and starting periods at a younger age are all linked to a higher risk of cardiovascular problems in women, according to new research.

Medtronic announced five-year bioprosthetic valve dysf­unction (BVD) data for the CoreValve/Evolut  platform, the first and only transcatheter aortic valve replacement (TAVR) platform to show significantly better valve performance...

The therapy benefited patients by improving ejection fraction, and reducing the risk of heart attack or stroke, especially in patients who have high levels of inflammation.

GENT, Belgium — FEops announced the publication of the PREDICT-LAA study in JACC: Cardiovascular Interventions, showing that Left Atrial Appendage Closure (LAAC) procedures planned by means of FEops HEARTguide™ resulted in significant...

Syntach AB ("Syntach") is pleased to announce that the Company's Syntach Cardiac Support system (Syntach CS) has been selected for an oral presentation in the Best Innovation Competition to be held during the CRT 2023 annual meeting.

The CONFORMAL Early Feasibility Study (EFS) evaluated the use of angiography compared to transesophageal echocardiogram (TEE) for left atrial appendage (LAA) assessment.

Disabilities were underreported in clinical trial data and commonly used as a basis for exclusion from trial participation in an analysis of 80 recent trials involving cardiovascular outcomes.

People who suffer from insomnia were 69% more likely to have a heart attack compared to those who didn’t have the sleep disorder during an average nine years of follow-up.